{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T10:11:06Z","timestamp":1737627066184,"version":"3.33.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1984,6,1]],"date-time":"1984-06-01T00:00:00Z","timestamp":454896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1984,6,1]],"date-time":"1984-06-01T00:00:00Z","timestamp":454896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1984,6]]},"DOI":"10.1136\/ard.43.3.511","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"511-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria."],"prefix":"10.1016","volume":"43","author":[{"given":"A.P","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J","family":"Prouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M","family":"Gumpel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","volume-title":"Current Clinical Practice Series 7","author":"Auranofin","year":"1982","unstructured":"Auranofin. Current Clinical Practice Series 7. Amsterdam: Excerpta Medica, 1982."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cpt1975174467","article-title":"Pseudoproteinaemia in tolmetin treated patients","volume":"17","author":"E, Ehrlich G.; F, Wortham G.","year":"1975","unstructured":"Ehrlich G E, Wortham G F. Pseudoproteinaemia in tolmetin treated patients. Clin Pharmacol Ther 1975; 17: 467-8.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/art.1780221223","article-title":"Reversible proteinuria as a complication of oral gold therapy","volume":"22","author":"Revach, M.; L, Freed R.; E, Ehrlich G.","year":"1979","unstructured":"Revach M, Freed R L, Ehrlich G E. Reversible proteinuria as a complication of oral gold therapy. Arthritis Rheun 1979; 22: 1417-8.","journal-title":"Arthritis Rheun"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-97-4-563","article-title":"Membranous glomerulonephritis as a complication of oral gold therapy","volume":"97","author":"J, Plaza J.; G, Herrero; A, Borat","year":"1982","unstructured":"Plaza J J, Herrero G, Borat A, et al. Membranous glomerulonephritis as a complication of oral gold therapy. Ann Intern Med 1982; 97: 563-4.","journal-title":"Ann Intern Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM198008073030602","article-title":"HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis","volume":"303","author":"H, Wooley P.; J, Griffin; S, Panayi G.; R, Batchelor J.; I, Welsh K.; J, Gibson T.","year":"1980","unstructured":"Wooley P H, Griffin J, Panayi G S, Batchelor J R, Welsh K I, Gibson T J. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med 1980; 303: 300-2.","journal-title":"N Engl J Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724132694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724132694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.43.3.511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T06:13:32Z","timestamp":1737526412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724132694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,6]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1984,6]]}},"alternative-id":["S0003496724132694"],"URL":"https:\/\/doi.org\/10.1136\/ard.43.3.511","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1984,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.43.3.511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1984 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}